Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity

By Neuroth M.   MacConnell P.   Stronach F.   Vamplew P.   Shimada Y.   Watanabe G.   Yamasaki S.   Maeda M.   Kawabe A.   Kaganoi J.-I.   Itami A.   Fukumoto M.   Kanda Y.   Imamura M.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 987-993

Elsevier

Access to resources Recommend Favorite

Expression of p53 Protein as a Prognostic Factor in Patients With Gastric Cancer

By Victorzon M.   Nordling S.   Haglund C.   Lundin J.   Roberts P.J.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 215-220

Elsevier

Access to resources Recommend Favorite

Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival

By Offersen Birgitte V.   Knap Marianne M.   Horsman Michael R.   Verheijen Jan   Hanemaaijer Roeland   Overgaard Jens  

Acta Oncologica, Vol. 49, Iss. 8, 2010-11 ,pp. : 1283-1287

Informa Healthcare

Access to resources Recommend Favorite

Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence

By Eissa Sanaa  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1286-1294

Humana Press, Inc

Access to resources Recommend Favorite

Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival

By Nitti D.   Belluco C.   Montesco M.C.   Bertorelle R.   Da Pian P.P.   Fassina A.   Ninfo V.   Chieco-Bianchi L.   Lise M.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 851-855

Elsevier

Access to resources Recommend Favorite